Clinical Trial Update: Safety and Immunogenicity of Hecolin® in Healthy Pregnant Women [Phase 2]

View source ↗

Summary

This entry describes a Phase 2 clinical trial evaluating the safety and immunogenicity of Hecolin in healthy pregnant women. The study, sponsored by the Interna…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis E

Drugs mentioned

• Hecolin (HEV-239 recombinant vaccine)

Snippet

Sponsor: International Vaccine Institute | Conditions: Hepatitis E Infection | Phase 2 | Status: RECRUITING